This study systematically reviews the overall situation of drug security for rare diseases in Shanghai, analyzes the existing problems, and expounds the value and feasibility of drug security for rare diseases. This study also proposes that under the new policy situation, Shanghai should give full play to the advantages of good economic foundation, strong social power and sufficient management experience, and actively explore a comprehensive drug security model of rare disease guided by the government, integrate resources of medical security, social assistance and charity support, and gather the strength of the whole society. It is necessary to accelerate the exploration of the establishment of a special fund for rare disease medication with government guidance and full participation of social forces. Improve drug security for rare diseases by stages, enhance supporting mechanism, support medical science and technology innovation, so as to provide reference for the country and other regions.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |